Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9526
iShares MSCI New Zealand ETF
ENZL
$82.3M
| $234K | ﹤0.01% |
5,292
-10,494
| -66% | -$492K |
|
9527
CALL
Vanguard FTSE Pacific ETF
VPL
$8.7B
| $234K | ﹤0.01% |
3,500
-2,200
| -39% | -$153K |
|
|
CONN
9528
DELISTED
Conn's Inc.
CONN
| $234K | ﹤0.01% |
59,239
-43,058
| -42% | -$179K |
|
9529
PUT
Vital Farms
VITL
$475M
| $234K | ﹤0.01% |
20,200
+17,200
| +573% | +$198K |
|
|
MDRX
9530
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $234K | ﹤0.01% |
17,800
+17,600
| +8,800% | +$231K |
|
9531
CALL
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
| $234K | ﹤0.01% |
12,800
+5,400
| +73% | +$104K |
|
9532
Brookfield Renewable
BEPC
$6.55B
| $234K | ﹤0.01% |
9,762
+7,493
| +330% | +$217K |
|
9533
PUT
Allot
ALLT
$373M
| $234K | ﹤0.01% |
107,200
+66,200
| +161% | +$163K |
|
9534
CALL
iShares MSCI India Small-Cap ETF
SMIN
$767M
| $234K | ﹤0.01% |
3,700
+400
| +12% | +$24.5K |
|
9535
CALL
Zai Lab
ZLAB
$2.9B
| $233K | ﹤0.01% |
9,600
+1,700
| +22% | +$45.3K |
|
9536
CALL
AdvanSix
ASIX
$446M
| $233K | ﹤0.01% |
7,500
-3,600
| -32% | -$125K |
|
|
TSE
9537
CALL
DELISTED
Trinseo
TSE
| $233K | ﹤0.01% |
28,500
+19,300
| +210% | +$245K |
|
9538
Five Point Holdings
FPH
$365M
| $233K | ﹤0.01% |
78,389
-26,131
| -25% | -$81.1K |
|
|
AVTA
9539
PUT
DELISTED
Avantax, Inc. Common Stock
AVTA
| $233K | ﹤0.01% |
9,100
-51,900
| -85% | -$1.23M |
|
|
ACH
9540
PUT
Accendra Health
ACH
$81.5M
| $233K | ﹤0.01% |
14,400
| – | – |
|
9541
CALL
JPMorgan BetaBuilders Canada ETF
BBCA
$11.4B
| $233K | ﹤0.01% |
+4,000
| New | +$242K |
|
9542
PUT
EyePoint Inc
EYPT
$391M
| $233K | ﹤0.01% |
29,100
+21,800
| +299% | +$239K |
|
9543
CALL
Metallus
MTUS
$910M
| $232K | ﹤0.01% |
10,700
-10,900
| -50% | -$238K |
|
|
NREF
9544
CALL
NexPoint Real Estate Finance
NREF
$319M
| $232K | ﹤0.01% |
14,200
+5,800
| +69% | +$96.1K |
|
9545
Hull Tactical US ETF
HTUS
$166M
| $232K | ﹤0.01% |
+7,365
| New | +$244K |
|
9546
PUT
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.46B
| $232K | ﹤0.01% |
+10,600
| New | +$242K |
|
9547
CALL
New Mountain Finance
NMFC
$707M
| $232K | ﹤0.01% |
17,900
+6,900
| +63% | +$88K |
|
9548
908 Devices
MASS
$429M
| $231K | ﹤0.01% |
34,754
+20,030
| +136% | +$139K |
|
9549
Gentex
GNTX
$5.02B
| $231K | ﹤0.01% |
7,107
-20,974
| -75% | -$672K |
|
|
QVCGA
9550
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $231K | ﹤0.01% |
7,624
-84
| -1% | -$3.54K |
|
Similar funds
Citadel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
- Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.